Related Experiment Video
Updated: Feb 2, 2026
11:10
Dissecting Cell-Autonomous Function of Fragile X Mental Retardation Protein in an Auditory Circuit by In Ovo Electroporation
Published on: July 6, 2022
2.7K
Do comorbidities among patients with mental retardation differ across various age groups?
Sharda Singh1, Lokesh Kumar Singh1, Manoj Sahu2
1Department of Psychiatry, All India Institute of Medical Sciences, Tatibandh, Raipur, Chhattisgarh, 492099, India.
Asian Journal of Psychiatry
|November 23, 2018
Summary
Psychiatric comorbidities are common in patients with intellectual disabilities (ID). Behavioral impairment and epilepsy were the most frequent comorbidities across all age groups in this study.
Area of Science:
- Neuroscience
- Psychiatry
- Genetics
Background:
- Intellectual disabilities (ID) are associated with a high prevalence of comorbidities.
- Understanding the distribution of these comorbidities across different age groups is crucial for effective management.
Purpose of the Study:
- To investigate the prevalence and patterns of psychiatric comorbidities in patients with intellectual disabilities.
- To analyze the differences in comorbidity distribution across various age groups.
Main Methods:
- Retrospective analysis of data from 426 patients diagnosed with intellectual disabilities (ID).
- Intelligence assessment data was collected from 546 referred samples.
- Psychiatric comorbidities were identified and categorized.
Main Results:
- 42.3% of patients with ID exhibited psychiatric comorbidities.
- The prevalence ratio of psychiatric comorbidity associated with ID was 2.11.
- Behavioral impairment and epilepsy were the most frequent comorbidities, regardless of age.
Conclusions:
- Behavioral impairment and epilepsy are the most common comorbidities in patients with intellectual disabilities.
- These comorbidities are prevalent across all age groups, highlighting the need for integrated care approaches.
Related Concept Videos
01:19Retarders
265
Retarders are chemical admixtures designed to extend the setting time, which is especially useful when there is a delay in sequential concrete pours to prevent cold joints and to achieve a cohesive structure. Retarders, when used in appropriate amounts, can also enhance the architectural appearance of exposed aggregate finishes.
The function of retarders is to delay the setting of concrete, and this effect can be measured using a penetration test. The retardation process involves adding...
The function of retarders is to delay the setting of concrete, and this effect can be measured using a penetration test. The retardation process involves adding...
265
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
236
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
236
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
703
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
703
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
262
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
262
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
215
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
215
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
253
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
253